ibusinesslines.com June 26, 2017

Synergy Pharmaceuticals Inc 174% Potential Upside Now Implied by Rodman & Renshaw

25 January 2017, 08:48 | Kelvin Horton

Synergy Pharmaceuticals, Inc. (SGYP) Stock Price Decreases -12.18%

Stocks Breaking Stillness on Analysts Estimates: Synergy Pharmaceuticals (NASDAQ:SGYP), Biogen Inc. (NASDAQ:BIIB)

According to consensus agreement of 6 analysts Synergy Pharmaceuticals Inc (NASDAQ: SGYP) will report earnings per share of $-0.2 in their quarterly report and it is expected to announce the company's results on 2/23/17. BlackRock Fund Advisors now owns 8,824,549 shares of the biopharmaceutical company's stock valued at $33,533,000 after buying an additional 3,120,748 shares during the last quarter.

If we look at the Volatility of the company, Week Volatility is 6.69%, whereas Month Volatility is at 6.15%. Currently, 15.3% of the shares of the company are sold short.

Executives hold 0.39 percent of the stock. Victory Capital, an Ohio-based fund reported 3,651 shares.

Biogen Inc. (NASDAQ: BIIB) [Trend Analysis] retains strong position in active trade, as shares scoring 0.11% to $280.66 in active trade session, while looking at the shares volume, around 1.97 Million shares have changed hands in this session. D E Shaw And Company holds 0% or 188,211 shares in its portfolio. Canaccord Genuity restated a "buy" rating and issued a $13.00 price objective on shares of Synergy Pharmaceuticals in a research report on Friday, October 21st. Dividends are mostly given in terms of cash payments, property or as shares of stock. The company has 0.80% insider ownership. Blackrock Japan Communication Ltd accumulated 644 shares or 0% of the stock.

05/12/2015 - Synergy Pharmaceuticals, Inc. was upgraded to " by analysts at Zacks.

Insider Transactions: Since September 16, 2016, the stock had 0 insider buys, and 4 sales for $20.41 million net activity. BRANCACCIO JOHN P had sold 2,518 shares worth $14,504 on Monday, September 19.

10/24/2016 - Synergy Pharmaceuticals, Inc. had its " rating reiterated by analysts at H.C. Wainwright. After $-0.22 actual EPS reported by Synergy Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts -22.73% EPS growth.

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) has its dividend (annual) of 0 while its Dividend Yield (annual) is 0%.

Trulance met the main goals of two late-stage studies in December on irritable bowel syndrome patients with constipation (IBS-C). "Synergy Pharmaceuticals, Inc.is headquartered in New York, New York". Large ranges indicate high volatility and small ranges indicate low volatility. Current price places the company's stock 28.95% away from its 200-day simple moving average, 5.13%, away from the 50-day average and also -4.19% away from 20-day average. Swiss National Bank increased its stake in shares of Synergy Pharmaceuticals by 67.8% in the third quarter. Rodman & Renshaw maintained Synergy Pharmaceuticals Inc (NASDAQ: SGYP) rating on Friday, December 23. It has been assigned a low target price of $6.5 and a high target price of $18. The firm has " rating given on Thursday, October 29 by Roth Capital. (NASDAQ: SGYP) now has a Mean Price Target of $11.5. Higgins has a 32.4% average return when recommending SGYP, and is ranked #4247 out of 4361 analysts.

SGYP has been the subject of several recent research reports. (NASDAQ: SGYP) was down -7.80% during the last trading session, with a day high of 6.71. Analysts mean target price for Twilio Inc. The firm earned "Outperform" rating on Thursday, January 5 by Oppenheimer.

In Synergy Pharmaceuticals Inc. TRULANCE is the first drug created to replicate the function of uroguanylin, a naturally occurring and endogenous human gastrointestinal (GI) peptide that is thought to stimulate fluid secretion which results in a stool consistency associated with more regular bowel function.

Other News

Trending Now

Liverpool v Southampton: Can Jurgen Klopp inspire a cup comeback
Still, the season has still been fantastic to date and we back the manager and players to turn it round... I think that Liverpool will record a comfortable win which is why I am going with the -1 AH @ -126.

Pro Bowl Skills Showdown adds a WR Drone Drop competition
In the wake of so many issues this year, Dalton still had 4,206 passing yards and 18 touchdowns against just eight interceptions. It caps off a great week for the Daltons, as they announced another upcoming addition to their family.

Erin Andrews had cancer following trial; consulted Urban Meyer
She just got engaged to her boyfriend, Jarret Stoll, and once again, she will be covering the Super Bowl on February 5. And less than a month later, her doctor told her that she is now cancer free.

State Senators Urge Bill Kintner of Papillion to Resign After Second Scandal
The state webpage would provide information about alternatives to abortion and a list of clinics that provide free ultrasounds. The lawmaker was already in hot water after paying $1,000 fine a year ago for misuse of state property.

Trump Resigns From More Than 400 Companies
ProPublica reports that much of the necessary paperwork in states including Florida wasn't filed until late Monday. A listing for the Trump Miami Resort Management Member Corp., for example, showed Donald Trump Jr.as director.

Analyst Outlook on Price Target: Ford Motor Company (NYSE:F)
Following the transaction, the president now directly owns 153,850 shares in the company, valued at approximately $5,692,450. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink .

Scientists have created a bioprinter that can 3D print skin
Experts said instead of using cartridges and colored inks, they used bioink injectors composed of biological components. A computer controls the bioprinting process in order to precisely deposit the bio-inks on a print bed to make the skin.